Common gene mutations associated with NSCLC include In review epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK) gene mutations (Forsythe et al., 2020). This evidence concerns the gene ALK and non-small cell lung carcinoma.